Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Chronic ProgressiveSclerosisAmyotrophic Lateral SclerosisTuberous SclerosisEncephalomyelitis, Autoimmune, ExperimentalDemyelinating DiseasesMagnetic Resonance ImagingOptic NeuritisMyelin Basic ProteinBrainScleroderma, SystemicOligoclonal BandsInterferon-betaMyelin SheathSpinal CordMyelin-Oligodendrocyte GlycoproteinMyelin ProteinsDisability EvaluationOligodendrogliaMyelin-Associated GlycoproteinDisease ProgressionNeuromyelitis OpticaSensitivity and SpecificityCentral Nervous SystemAtrophyMyelin Proteolipid ProteinImmunologic FactorsCase-Control StudiesDelayed DiagnosisEarly DiagnosisSeverity of Illness IndexHLA-DR2 AntigenEncephalomyelitis, Acute DisseminatedPrenatal DiagnosisRetrospective StudiesAge of OnsetDiffuse Cerebral Sclerosis of SchilderRecurrenceNerve Fibers, MyelinatedTime FactorsCuprizoneReproducibility of ResultsNervous System DiseasesPropylene GlycolsFollow-Up StudiesDisease Models, AnimalDemyelinating Autoimmune Diseases, CNSCerebrospinal FluidAxonsTheilovirusTreatment OutcomeCerebrospinal Fluid ProteinsT-LymphocytesProspective StudiesNeurologic ExaminationCohort StudiesHLA-DRB1 ChainsAutoimmune DiseasesRemission, SpontaneousMicrogliaOptic NerveImmunoglobulin GBiological MarkersAutoantibodiesDiagnosisFatigueImmunosuppressive AgentsPredictive Value of TestsCardiovirus InfectionsAutoimmunityGenetic Predisposition to DiseaseMethylprednisoloneMice, Inbred C57BLRisk FactorsBlood-Brain BarrierStatistics, NonparametricEvoked Potentials, VisualImage EnhancementScleroderma, DiffuseAstrocytesDiagnostic ErrorsPrognosisEnzyme-Linked Immunosorbent AssayHLA-DR AntigensCentral Nervous System DiseasesBiopsyGadoliniumAutoantigensNeuritisMyelitis, TransverseAcute DiseaseDisabled PersonsSpinal Cord DiseasesInflammationTomography, X-Ray ComputedImage Processing, Computer-AssistedNerve DegenerationCells, Cultured